IGHG3 and COVID-19: Further to this, patients with severe COVID-19, particularly males, have been shown to generate IgG1 antibodies with significantly reduced Fc fucosylation, in addition to increased IgG3 antibodies when compared to patients with mild symptoms and children, indicating that severe COVID-19 resulted from the production of pro-inflammatory IgG antibodies [38].